Moreover, treating neutrophils cultured in tumor cell-conditioned medium with Sivelestat (a PR3 inhibitor), Cl-amidine (a PAD4/histone citrullination inhibitor), or DNase I (which degrades NETs) effectively blocked NET formation and cathepsin C activity. Here, PRTN3 is linked to neoplasm.